市場調查報告書
商品編碼
1451764
2024-2032 年按產品類型(疫苗、藥品、飼料添加劑)、最終用戶(乳牛場、獸醫院等)和地區分類的牛隻保健市場Cattle Healthcare Market by Product Type (Vaccines, Pharmaceuticals, Feed additives), End User (Dairy farms, Veterinary hospitals, and Others), and Region 2024-2032 |
2023年,全球牛隻保健市場規模達到88億美元。展望未來, IMARC Group預計到2032年市場規模將達到122億美元,2024-2032年複合年成長率(CAGR)為3.62%。對動物性蛋白質需求的增加、可支配收入水準的擴大以及人畜共患疾病盛行率的增加是推動市場發展的一些關鍵因素。
牛保健是指對牛身心健康各方面的管理。它涉及預防、診斷和治療健康問題,以維持動物的福祉和生產力。牛隻保健的主要目標包括防止疾病傳播、確保最佳營養和生長、提供安全清潔的環境以及實施有效的疾病控制措施。定期監測和評估牛群的健康狀況對於及早發現和治療潛在的健康問題至關重要。有效的牛保健需要結合良好的管理實踐、獸醫護理和適當的藥物使用。這可能包括疫苗接種計劃、寄生蟲控制、營養管理和疾病監測計劃。此外,實施適當的牛隻保健措施可以改善動物福利、提高生產力並促進畜牧業的永續發展。
推動市場的主要因素之一是由於全球人口不斷成長而導致對動物蛋白質的需求增加。此外,由於群眾可支配收入水準不斷提高,包括牛在內的牲畜產量增加,從而創造了積極的市場前景。除此之外,牛結核病、布魯氏菌病和沙門氏菌病等人畜共通傳染病的日益流行,使人們更加重視動物健康和疾病控制措施。除此之外,畜牧生產者對動物健康和福利的重要性的認知不斷提高,以確保其經營的永續性,這對市場成長產生了積極影響。與此一致的是,乳製品產業的指數級成長,特別是在新興經濟體,正在推動市場成長。除了這些因素之外,畜牧生產投資的增加導致對牛保健產品和服務的需求增加,以支持該行業。此外,日益成長的環境問題導致人們越來越關注促進永續畜牧生產的牛隻保健產品和服務。此外,世界各國政府正在採取措施促進動物健康和福利,例如疾病監測計畫、疫苗接種運動和法規,以確保獸藥的安全和道德使用。此外,重大技術進步正在導致疫苗、檢測和藥物等新型創新牛隻保健產品和服務的開發,從而創造了積極的市場前景。
The global cattle healthcare market size reached US$ 8.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.2 Billion by 2032, exhibiting a growth rate (CAGR) of 3.62% during 2024-2032. The augmenting demand for animal protein, expanding disposable income levels, and increasing prevalence of zoonotic diseases represent some of the key factors driving the market.
Cattle healthcare refers to the management of all aspects of the physical and mental health of cattle. It involves preventing, diagnosing, and treating health issues in order to maintain the well-being and productivity of the animals. The primary objectives of cattle healthcare include preventing the spread of diseases, ensuring optimal nutrition and growth, providing a safe and clean environment, and implementing effective disease control measures. Regular monitoring and evaluation of the herd's health are essential for the early detection and treatment of potential health issues. Effective cattle healthcare requires a combination of good management practices, veterinary care, and appropriate use of medications. This may include vaccination programs, parasite control, nutritional management, and disease surveillance programs. Moreover, implementing proper cattle healthcare practices can improve animal welfare, enhance productivity, and promote sustainability in the livestock industry.
One of the primary factors driving the market is the augmenting demand for animal protein due to the growing population globally. Additionally, on account of the expanding disposable income levels of the masses, there is a rise in the production of livestock, including cattle, thus creating a positive market outlook. Other than this, the increasing prevalence of zoonotic diseases, such as bovine tuberculosis, brucellosis, and salmonellosis, is creating a greater emphasis on animal health and disease control measures. Besides this, the rising awareness among livestock producers regarding the importance of animal health and welfare to ensure the sustainability of their operations is positively influencing market growth. In line with this, the exponential growth in the dairy industry, specifically in emerging economies, is propelling the market growth. Apart from these factors, the increasing investment in livestock production is leading to increased demand for cattle healthcare products and services to support the industry. Furthermore, the growing environmental concerns have led to an increasing focus on cattle healthcare products and services that promote sustainable livestock production. Moreover, governments across the world are taking initiatives to promote animal health and welfare, such as disease surveillance programs, vaccination campaigns, and regulations, to ensure the safe and ethical use of veterinary drugs. Furthermore, significant technological advancements are leading to the development of new and innovative cattle healthcare products and services, such as vaccines, tests, and medicines, thus creating a positive market outlook.
IMARC Group provides an analysis of the key trends in each segment of the global cattle healthcare market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on the product type and end user.
Vaccines
Pharmaceuticals
Analgesics
Anti-infective
Anti-inflammatory
Parasiticides
Others
Feed additives
Medicinal
Nutritional
The report has provided a detailed breakup and analysis of the cattle healthcare market based on the product type. This includes vaccines, pharmaceuticals (analgesics, anti-infectives, anti-inflammatory, parasiticides, and others), and feed additives (medicinal and nutritional).
Dairy farms
Veterinary hospitals
Others
A detailed breakup and analysis of the cattle healthcare market based on the end user has also been provided in the report. This includes dairy farms, veterinary hospitals, and others. According to the report, veterinary hospitals accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cattle healthcare. Some of the factors driving the North America cattle healthcare market included increasing demand for animal protein, technological advancements in veterinary medicine, and rising awareness of animal welfare.
The report has also provided a comprehensive analysis of the competitive landscape in the global cattle healthcare market. Detailed profiles of all major companies have also been provided. Some of the companies covered include BioZyme Inc., Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn AG & Co. KG), Ceva Sante Animate, Elanco Animal Health Incorporated, Merck & Co. Inc., Virbac, Zoetis Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.